4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000018
Options or other derivatives
- EVP, Chief Scientific Officer acquired 27,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-01-02 | Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) | +27,200 | $52.87 | 2034-01-01 | 27,200 | 27,200 | D |
Loading xslF345X05/edgardoc.xml…